Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)
Praxis Precision Medicines (PRAX) recorded quarterly Revenue of $7.5 million in Q4 2024, up 2371.19% quarter-over-quarter from $302000.0 in Q3 2024, and up 1349.13% on a YoY basis from $515000.0 in Q1 2024.
Praxis Precision Medicines (PRAX) Revenue (2023 - 2024) Analysis & Trends
Praxis Precision Medicines' Revenue history runs 2 years deep, the most recent figure standing at $7.5 million for Q4 2024.
- In Q4 2024, Revenue rose 1349.13% year-over-year to $7.5 million; the TTM figure through Sep 2025 stood at $7.5 million (up 364.98% YoY), while the FY2024 annual figure was $8.6 million, up 249.53% from the prior year.
- Revenue was $7.5 million for Q4 2024 at Praxis Precision Medicines, up from $302000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $7.5 million in Q4 2024 to a low of $302000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.46 Mn |
| Sep 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 431,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Sep 30, 2023 | 468,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 683,000.00 |